The invention defines interdependent biofactors and biomolecules, and clinically useful formulations that are comprised of them. The active agents are demonstrated to be complementary in their physiologic functions especially as these relate to the quenching of free radicals and to the support of endothelial physiology, the reduction of hyperinsulinemia and improvements in vascular health. The active components of the invention are selected for inclusion in precise combinations specifically because they improve these various conditions and physiological functions, and by so doing reduce a variety of risks associated with hearing loss and tinnitus. The resulting enhancement of general systemic vascular health, improvement in local VIII
th
nerve vascular health, modulation of conditions surrounding blood fluid dynamics, the consequences of hyperinsulinemia, and improvements in free radical defenses, all reduce the potential for cochlear hair cell death and VIII
th
nerve atrophy, and the hearing loss and possible deafness that accompany them.
本发明定义了相互依存的
生物因子和
生物分子,以及由它们组成的临床实用配方。活性成分在生理功能上具有互补性,特别是在淬灭自由基、支持内皮生理机能、降低高
胰岛素血症和改善血管健康方面。本发明的活性成分之所以被选入精确的组合中,特别是因为它们能改善这些不同的状况和生理功能,从而降低与听力损失和耳鸣相关的各种风险。由此增强全身血管健康,改善局部 VIII
神经血管健康
神经血管健康、调节血液流体动力学、高
胰岛素血症的后果以及改善自由基防御能力,所有这些都能降低耳蜗毛
细胞死亡和 VIIIth 神经损伤的可能性。
神经萎缩
神经萎缩的可能性,以及随之而来的听力损失和可能的耳聋。